Approval Year
Substance Class |
Nucleic Acid
Created
by
admin
on
Edited
Sat Dec 16 09:24:14 GMT 2023
by
admin
on
Sat Dec 16 09:24:14 GMT 2023
|
Nucleic Acid Type | OLIGONUCLEOTIDE |
Nucleic Acid Subtype | Other EXON-SKIPPING |
Sequence Type | COMPLETE |
Record UNII |
X8UHF7SX0R
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
690019
Created by
admin on Sat Dec 16 09:24:14 GMT 2023 , Edited by admin on Sat Dec 16 09:24:14 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1422958-19-7
Created by
admin on Sat Dec 16 09:24:14 GMT 2023 , Edited by admin on Sat Dec 16 09:24:14 GMT 2023
|
PRIMARY | |||
|
2480096
Created by
admin on Sat Dec 16 09:24:14 GMT 2023 , Edited by admin on Sat Dec 16 09:24:14 GMT 2023
|
PRIMARY | |||
|
X8UHF7SX0R
Created by
admin on Sat Dec 16 09:24:14 GMT 2023 , Edited by admin on Sat Dec 16 09:24:14 GMT 2023
|
PRIMARY | |||
|
Casimersen
Created by
admin on Sat Dec 16 09:24:14 GMT 2023 , Edited by admin on Sat Dec 16 09:24:14 GMT 2023
|
PRIMARY | |||
|
C169830
Created by
admin on Sat Dec 16 09:24:14 GMT 2023 , Edited by admin on Sat Dec 16 09:24:14 GMT 2023
|
PRIMARY | |||
|
FG-220
Created by
admin on Sat Dec 16 09:24:14 GMT 2023 , Edited by admin on Sat Dec 16 09:24:14 GMT 2023
|
PRIMARY | |||
|
DB14984
Created by
admin on Sat Dec 16 09:24:14 GMT 2023 , Edited by admin on Sat Dec 16 09:24:14 GMT 2023
|
PRIMARY | |||
|
X8UHF7SX0R
Created by
admin on Sat Dec 16 09:24:14 GMT 2023 , Edited by admin on Sat Dec 16 09:24:14 GMT 2023
|
PRIMARY | |||
|
10354
Created by
admin on Sat Dec 16 09:24:14 GMT 2023 , Edited by admin on Sat Dec 16 09:24:14 GMT 2023
|
PRIMARY |
Sugar | Site Range | Site Count |
---|---|---|
morpholino | 1_1-1_22 | 22 / 22 |
Linkage | Site Range | Site Count |
---|---|---|
Phosphoryldimethylamine | 1_2-1_22 | 21 / 21 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INDUCER |
Exon 45 skipping
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Structural Modifications
Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
---|---|---|---|---|---|---|
NUCLEOSIDE_SUBSTITUTION | [1_4] [1_9] [1_12] [1_17] [1_18] [1_21] | MORPHOLINO THYMIDINE | YML1Y6H5HD | |||
NUCLEOSIDE_SUBSTITUTION | [1_2] [1_3] [1_8] [1_15] | MORPHOLINO ADENOSINE | 3ZYB3DY5HB | |||
NUCLEOSIDE_SUBSTITUTION | [1_5] [1_13] [1_14] [1_16] [1_22] | MORPHOLINO GUANOSINE | XHA1WD2RB2 | |||
NUCLEOSIDE_SUBSTITUTION | [1_6] [1_7] [1_10] [1_11] [1_19] [1_20] | MORPHOLINO CYTIDINE | KFE1UKU3TI | |||
NUCLEOTIDE SUBSTITUTION | [1_1] | 5'-TERMINUS | CASIMERSEN 5'-CYTOSINE MODIFICATION | 8CQO07490I |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|